Structured evidence table for Macadamia Blood Lipids Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Macadamia Blood Lipids Meta-Analysis | Traditional risk factors for CKD development and progression include diabetes, hypertension, and obesity. | 1 | Lazzarin Taline (2025) | Nut consumption in chronic kidney disease: a systematic review |
| Macadamia Blood Lipids Meta-Analysis | In particular, inflammation and oxidative stress contribute to vascular injury, endothelial dysfunction, and accelerated atherosclerosis, which markedly increase the risk of cardiovascular morbidity and mortality in this population (). | 1 | Lazzarin Taline (2025) | Nut consumption in chronic kidney disease: a systematic review |
| Macadamia Blood Lipids Meta-Analysis | The National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidence-based dietary guidelines for the management of kidney diseases since 1999, with great emphasis on an individualized approach to monitor protein intake, as well as control sodium, potassium and phosphorus circulating levels to prevent complications. | 1 | Lazzarin Taline (2025) | Nut consumption in chronic kidney disease: a systematic review |
| Macadamia Blood Lipids Meta-Analysis | 1 1 2 3 Chronic kidney disease (CKD) is characterized by diminished kidney function, shown by a glomerular filtration rate of less than 60 mL/min per 1.73 m, or markers of kidney damage, or both, present for a minimum of 3 months, causing negative health implications (). | 1 | Lazzarin Taline (2025) | Nut consumption in chronic kidney disease: a systematic review |
| Macadamia Blood Lipids Meta-Analysis | Context Nut consumption is attributed to improvements in risk factors for cardiovascular disease (CVD), including high blood pressure (BP) and dyslipidemia. | 1 | Wong HY (2025) | Does Medication Status Impact the Effectiveness of Nuts in Altering Blood Pressure and Lipids? A Systematic Review and Meta-Analysis. |
| Macadamia Blood Lipids Meta-Analysis | Data analysis Nut consumption significantly reduced triglycerides (TG), total cholesterol, low-density lipoprotein cholesterol, very-low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B, with no effect on high-density lipoprotein cholesterol or blood pressure. | 1 | Wong HY (2025) | Does Medication Status Impact the Effectiveness of Nuts in Altering Blood Pressure and Lipids? A Systematic Review and Meta-Analysis. |
| Macadamia Blood Lipids Meta-Analysis | However, it is unclear whether these effects are altered with concurrent treatment with BP and lipid-lowering medication. | 1 | Wong HY (2025) | Does Medication Status Impact the Effectiveness of Nuts in Altering Blood Pressure and Lipids? A Systematic Review and Meta-Analysis. |
Source documents